|

Effect of Breather in COPD Patients with Intermittent Claudication

RECRUITINGN/ASponsored by Cairo University
Actively Recruiting
PhaseN/A
SponsorCairo University
Started2024-07-30
Est. completion2024-12-20
Eligibility
Age50 Years – 60 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06529185

Summary

The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.

Eligibility

Age: 50 Years – 60 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
* All patients will be clinically and medically stable when attending the study.
* Body mass index (BMI) is 18.5 to 24.9 kg/m2.
* History of unilateral exertional leg pain,
* Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
* And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.

Exclusion Criteria:

* cardiovascular insufficiency,
* Recent myocardial infarction,
* heart failure,
* arrhythmia,
* DVT,
* Intracranial hypertension,
* Pneumonia,
* kidney failure,
* fractures,
* uncooperative patients,
* cognitive impairment preventing a patient from participation in exercises.

Conditions2

COPDPAD

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.